Evolving attitudes to Alzheimer's disease among the general public and caregivers in Europe: findings from the IMPACT survey.
Understanding and appreciating the awareness of, and attitudes towards, Alzheimer's disease (AD) in the general public is of paramount importance to those charged with the development of health care policy. Furthermore, it is essential that this policy be formulated with consideration given to both the attitudes of the general population and to those within society more directly affected by AD; namely, the caregivers of patients with the disease. In the IMPACT survey, approximately 1000 members of the general public and 250 caregivers in 5 European countries (France, Germany, Italy, Spain, and the United Kingdom) completed a 30-minute, Web-based questionnaire. In this article, we compare and contrast the attitudes and opinions of these populations in an attempt to define specific themes. Indeed, caregivers were more concerned about consequences of growing old and were more fearful of AD than general public respondents, although a high proportion in both groups acknowledged the significant impact of the disease. Similarly, although most respondents in the 2 groups recognised that early signs and symptoms of AD are difficult to detect, caregivers were more skeptical of the abilities of both primary physicians and specialists to detect these early signs and symptoms. In terms of treatment, caregivers were less convinced of the effectiveness of treatment beyond the early stages of AD and more likely to agree that current treatments are associated with side effects. Respondents in both groups had a negative view of their government's investment in AD, but caregivers, particularly those in France, Spain and the United Kingdom, were more likely to feel that their government acts as a barrier to treatment. Some survey respondents from the 2 groups also had a negative view of their governments' attempts to raise awareness of AD and make its treatment a high priority. Overall, comparison of responses from these 2 groups suggests that caregivers' personal experiences of AD profoundly affect their attitudes and perceptions surrounding the disease.
Wortmann
M
M
Alzheimer's Disease International, London, UK. m.wortmann@alz.co.uk
Andrieu
S
S
Mackell
J
J
Knox
S
S
D000375:Aging / Q000523:psychology; D000544:Alzheimer Disease / Q000175:diagnosis / Q000628:therapy; D001294:Attitude to Health; D017028:Caregivers; D003625:Data Collection; D003695:Delivery of Health Care / Q000592:standards; D005060:Europe; D005239:Fear; D006076:Government; D007722:Health Knowledge, Attitudes, Practice; D006291:Health Policy; D006292:Health Priorities; D006801:Humans; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
Neurology. 2001 Aug 14;57(3):481-8
11502917
N Engl J Med. 2003 Apr 3;348(14):1333-41
12672860
J Nutr Health Aging. 2010 Aug;14(7):525-30
20818466
Curr Med Res Opin. 2009 Nov;25(11):2577-87
19735164
Arch Intern Med. 2000 Oct 23;160(19):2964-8
11041904
Dement Geriatr Cogn Disord. 2009;28(5):389-403
19893314
Int J Clin Pract Suppl. 2005 Mar;(146):17-24
15801187
Age Ageing. 2003 Nov;32(6):606-12
14600001
Neurology. 1998 Jan;50(1):136-45
9443470
Neurology. 2000 Jun 27;54(12):2269-76
10881251
BMJ. 1999 Mar 6;318(7184):633-8
10066203
Neurology. 2001 Aug 28;57(4):613-20
11524468
Dement Geriatr Cogn Disord. 2007;23(4):207-14
17290103
Neurology. 2004 Jul 27;63(2):214-9
15277611